Zacks Research Has Bullish Forecast for IRWD Q4 Earnings
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Zacks Research increased their Q4 2025 earnings per share estimates for Ironwood Pharmaceuticals in a research note issued on Wednesday, May 28th. Zacks Research analyst R. Department now expects that the biotechnology company will post earnings per share of $0.16 for the quarter, up from their prior […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Zacks Research increased their Q4 2025 earnings per share estimates for Ironwood Pharmaceuticals in a research note issued on Wednesday, May 28th. Zacks Research analyst R. Department now expects that the biotechnology company will post earnings per share of $0.16 for the quarter, up from their prior […]
